F-group (family)
206.1.1.70 Pkinase, ABC1
Ligands and drugs
2,120
Member domains
1,115
with ligand contacts (≤ 4 Å)
52.6% of members
1,029
with DrugDomain annotations
48.5% of members
520
with a DrugBank compound
24.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 206.1.1.70 belongs to X-group 206 Protein kinase/SAICAR synthase/ATP-grasp, which binds 10.2 ligand superclasses per 20 proteins, broader than 96% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02010 | STU | Staurosporine | 28 |
| DB12010 | — | Fostamatinib | 28 |
| DB04338 | SB4 | SB220025 | 25 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 23 |
| DB00171 | ATP | ATP | 20 |
| DB16833 | ADP | Adenosine disphosphate | 13 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 11 |
| DB07942 | I46 | 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine | 10 |
| DB08521 | SB2 | 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine | 8 |
| DB07101 | 4BM | Mirdametinib | 7 |
| DB07829 | GG5 | 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE | 7 |
| DB11982 | LCJ | GDC-0623 | 7 |
| DB02277 | BMU | 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea | 6 |
| DB08162 | M77 | Fasudil | 6 |
| DB11689 | 3EW | Selumetinib | 5 |
| DB01204 | MIX | Mitoxantrone | 4 |
| DB03044 | B96 | Doramapimod | 4 |
| DB03345 | BME | Mercaptoethanol | 4 |
| DB05239 | EUI | Cobimetinib | 4 |
| DB07307 | A17 | N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 186 |
| CL | CHLORIDE ION | 109 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 86 |
| STU | STAUROSPORINE | 30 |
| NAmetal | SODIUM ION | 28 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 27 |
| CAmetal | CALCIUM ION | 27 |
| SB4 | 4-(4-FLUOROPHENYL)-1-(4-PIPERIDINYL)-5-(2-AMINO-4-PYRIMIDINYL)-IMIDAZOLE | 25 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 20 |
| GG5 | 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE | 15 |
| A1AHE | N-[3-fluoro-4-({7-[(3-fluoropyridin-2-yl)oxy]-4-methyl-2-oxo-2H-1-benzopyran-3-yl}methyl)pyridin-2-yl]-N'-methylsulfuric diamide | 14 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 13 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 11 |
| LCJ | 5-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide | 11 |
| I46 | 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine | 10 |
| IRG | N~4~-cyclopropyl-2-phenylquinazoline-4,7-diamine | 10 |
| SB2 | 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE | 10 |
| VFS | N-[(1S)-2-hydroxy-1-phenylethyl]-3-methoxy-4-(1H-pyrazol-4-yl)benzamide | 9 |
| 5YK | 6-(2-fluoranylpyridin-4-yl)-~{N}-[(1~{R})-1-(3-methoxyphenyl)ethyl]pyridine-3-carboxamide | 8 |
| 5YS | ~{N}-[(1~{R})-1-(3-methoxyphenyl)ethyl]-4-pyridin-4-yl-piperidine-1-carboxamide | 8 |